2018 Guidelines for the Management of Dyslipidemia in Korea

Overview

Journal J Lipid Atheroscler

Date 2020 Aug 22

PMID 32821702

Citations 86

Authors

Eun-Jung Rhee

Hyeon Chang Kim

Jae Hyeon Kim

Eun Young Lee

Byung Jin Kim

Eun Mi Kim

YoonJu Song

Jeong Hyun Lim

Hae Jin Kim

Seonghoon Choi

Min Kyong Moon

Jin Oh Na

Kwang-Yeol Park

Mi Sun Oh

Sang Youb Han

Junghyun Noh

Kyung Hee Yi

Sang-Hak Lee

Soon-Cheol Hong

In-Kyung Jeong

Affiliations

Soon will be listed here.

Citing Articles

Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index.

Kim S, Yoo H Sci Rep. 2025; 15(1):7849.

PMID: 40050666 PMC: 11885555. DOI: 10.1038/s41598-025-92766-3.

Predicting low density lipoprotein cholesterol target attainment using machine learning in patients with coronary artery disease receiving moderate-dose statin therapy.

Han J, Kim Y, Kang H, Seo J, Choi H, Kim M Sci Rep. 2025; 15(1):5346.

PMID: 39948422 PMC: 11825908. DOI: 10.1038/s41598-025-88693-y.

Management of Elderly Patients with Chronic Kidney Disease.

Park Y, Hwang W Yonsei Med J. 2025; 66(2):63-74.

PMID: 39894039 PMC: 11790406. DOI: 10.3349/ymj.2024.0178.

A Multi-Center, Prospective, Observational Study to Evaluate the Therapeutic Effectiveness and Safety of an Olmesartan/Amlodipine Plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia.

Lee B, Kim B, Park J, Chung J, Park C, Kim J J Clin Med. 2025; 14(2).

PMID: 39860313 PMC: 11765630. DOI: 10.3390/jcm14020308.

Association of higher potency statin use with risk of osteoporosis and fractures in patients with stroke in a Korean nationwide cohort study.

Jeong J, Noh Y, Cho S, Hsieh C, Cho Y, Shin J Sci Rep. 2024; 14(1):30825.

PMID: 39730536 PMC: 11680841. DOI: 10.1038/s41598-024-81628-z.

References

Jee S, Jang Y, Oh D, Oh B, Lee S, Park S . A coronary heart disease prediction model: the Korean Heart Study. BMJ Open. 2014; 4(5):e005025. PMC: 4039825. DOI: 10.1136/bmjopen-2014-005025. View

Goldstein L, Amarenco P, Szarek M, Callahan 3rd A, Hennerici M, Sillesen H . Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2007; 70(24 Pt 2):2364-70. DOI: 10.1212/01.wnl.0000296277.63350.77. View

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted.... Eur Heart J. 2012; 33(13):1635-701. DOI: 10.1093/eurheartj/ehs092. View

Berglund L, Brunzell J, Goldberg A, Goldberg I, Sacks F, Murad M . Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97(9):2969-89. PMC: 3431581. DOI: 10.1210/jc.2011-3213. View

Pedersen H, Mulvad G, Seidelin K, Malcom G, Boudreau D . N-3 fatty acids as a risk factor for haemorrhagic stroke. Lancet. 1999; 353(9155):812-3. DOI: 10.1016/S0140-6736(98)05918-2. View

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

Marks D, Thorogood M, Neil H, Humphries S . A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis. 2003; 168(1):1-14. DOI: 10.1016/s0021-9150(02)00330-1. View

Landray M, Haynes R, Hopewell J, Parish S, Aung T, Tomson J . Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014; 371(3):203-12. DOI: 10.1056/NEJMoa1300955. View

Jones P, Davidson M, Stein E, Bays H, McKenney J, Miller E . Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003; 92(2):152-60. DOI: 10.1016/s0002-9149(03)00530-7. View

10.

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

11.

Kavazis A . Exercise preconditioning of the myocardium. Sports Med. 2009; 39(11):923-35. DOI: 10.2165/11317870-000000000-00000. View

12.

McCrindle B, Urbina E, Dennison B, Jacobson M, Steinberger J, Rocchini A . Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with.... Circulation. 2007; 115(14):1948-67. DOI: 10.1161/CIRCULATIONAHA.107.181946. View

13.

Stubbe I, Eskilsson J, Nilsson-Ehle P . High-density lipoprotein concentrations increase after stopping smoking. Br Med J (Clin Res Ed). 1982; 284(6328):1511-3. PMC: 1498412. DOI: 10.1136/bmj.284.6328.1511. View

14.

Grundy S, Cleeman J, Merz C, Brewer Jr H, Clark L, Hunninghake D . Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004; 44(3):720-32. DOI: 10.1016/j.jacc.2004.07.001. View

15.

. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J. 2006; 70(10):1249-55. DOI: 10.1253/circj.70.1249. View

16.

Touboul P, Hennerici M, Meairs S, Adams H, Amarenco P, Bornstein N . Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany,.... Cerebrovasc Dis. 2012; 34(4):290-6. PMC: 3760791. DOI: 10.1159/000343145. View

17.

Wanner C, Krane V, Marz W, Olschewski M, Mann J, Ruf G . Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005; 353(3):238-48. DOI: 10.1056/NEJMoa043545. View

18.

Moriguchi E, Fusegawa Y, Tamachi H, Goto Y . Effects of smoking on HDL subfractions in myocardial infarction patients: effects on lecithin-cholesterol acyltransferase and hepatic lipase. Clin Chim Acta. 1991; 195(3):139-43. DOI: 10.1016/0009-8981(91)90134-x. View

19.

. 2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation). Korean Circ J. 2016; 46(3):275-306. PMC: 4891593. DOI: 10.4070/kcj.2016.46.3.275. View

20.

Weng T, Yang Y, Lin S, Tai S . A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther. 2010; 35(2):139-51. DOI: 10.1111/j.1365-2710.2009.01085.x. View